John Overdeck’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$464K Buy
1,200
+200
+20% +$74.2K ﹤0.01% 4212
2026
Q1
$293K Sell
1,000
-1,000
-50% -$329K ﹤0.01% 4089
2025
Q4
$701K Sell
2,000
-4,800
-71% -$1.62M ﹤0.01% 3140
2025
Q3
$2.2M Buy
+6,800
New +$2.11M ﹤0.01% 2064
2022
Q1
Sell
-2,000
Closed -$927K 3152
2021
Q4
$927K Buy
+2,000
New +$841K ﹤0.01% 2621
2021
Q2
Sell
-4,100
Closed -$1.47M 4165
2021
Q1
$1.47M Buy
4,100
+3,400
+486% +$1.09M ﹤0.01% 1958
2020
Q4
$225K Sell
700
-300
-30% -$92.1K ﹤0.01% 3053
2020
Q3
$269K Sell
1,000
-2,500
-71% -$673K ﹤0.01% 2644
2020
Q2
$920K Buy
3,500
+2,500
+250% +$667K ﹤0.01% 1586
2020
Q1
$227K Sell
1,000
-12,700
-93% -$3.46M ﹤0.01% 2564
2019
Q4
$4.14M Sell
13,700
-10,300
-43% -$2.83M 0.01% 1079
2019
Q3
$5.76M Sell
24,000
-3,600
-13% -$986K 0.02% 795
2019
Q2
$7.79M Buy
27,600
+26,100
+1,740% +$7.13M 0.03% 704
2019
Q1
$430K Sell
1,500
-500
-25% -$145K ﹤0.01% 2365
2018
Q4
$525K Buy
+2,000
New +$550K ﹤0.01% 2066
2018
Q3
Sell
-12,100
Closed -$2.88M 3274
2018
Q2
$2.88M Buy
12,100
+11,100
+1,110% +$2.57M 0.01% 1376
2018
Q1
$220K Buy
+1,000
New +$235K ﹤0.01% 2937
2016
Q4
Sell
-2,000
Closed -$251K 3200
2016
Q3
$251K Buy
+2,000
New +$258K ﹤0.01% 2856
2016
Q1
Sell
-6,000
Closed -$837K 2886
2015
Q4
$837K Buy
+6,000
New +$827K ﹤0.01% 1629

Other funds holding ELV

John Overdeck's ELV Position: Q2 2026 in Review

John Overdeck increased its Elevance Health (ELV) stake by 12,762% in Q2 2026, buying an estimated $59.6M and bringing the position to 162,061 shares worth $62.7M. The position accounts for 0.05% of the portfolio, ranked #463.

John Overdeck first reported a position in ELV in Q4 2013 and has held it in 41 quarters since. The position peaked at $247M in Q2 2023. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • John Overdeck held 162,061 shares of Elevance Health worth $62.7M as of Q2 2026.
  • John Overdeck bought 160,801 Elevance Health shares in Q2 2026, an estimated $59.6M.
  • Elevance Health made up 0.05% of John Overdeck's portfolio in Q2 2026, its #463 holding.
  • John Overdeck first reported a position in Elevance Health in Q4 2013 and has held it in 41 quarters since.
  • John Overdeck's Elevance Health position peaked at $247M in Q2 2023.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.